SCHEMBL7330827

SCHEMBL7330827

CC(C)C(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](Cc1ccc(OCCN2CCOCC2)cc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
VIPR2 P41587 14/20 0.49
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
CYP3A4 P08684 2/20 0.43
ABCC3 O15438 1/20 0.43
ABCB11 O95342 1/20 0.43
ABCB1 P08183 1/20 0.43
TACR2 P21452 1/20 0.43
TBXAS1 P24557 1/20 0.43
SLC47A2 Q86VL8 1/20 0.43
SLC47A1 Q96FL8 1/20 0.43
CYP2D6 P10635 1/20 0.42
NR1I2 O75469 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329719 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL7329727 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL6366453 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL29624083 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL6366449 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL7336675 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL6366451 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL7362961 0.95 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL7339334 0.94 VIPR2 (0.51) VIPR2MMP1MMP2MMP9MMP8
SCHEMBL7330086 0.94 VIPR2 (0.48) VIPR2MMP1MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0434365-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1991-06-26 EP claimed
EP-0434365-A2 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1991-06-26 EP disclosed